Antibiotic Treatment for Enterococcus Prostatitis
Introduction to Treatment
- The body cannot reliably clear Enterococcus from the prostate without antibiotic treatment, and untreated bacterial prostatitis—including Enterococcus infections—requires antimicrobial therapy to prevent progression to chronic infection or serious complications, as recommended by the American Urological Association 1
Clinical Evidence Against Natural Resolution
- Untreated bacterial prostatitis typically progresses rather than resolves spontaneously, with stopping antibiotics prematurely leading to chronic bacterial prostatitis, demonstrating that even partial treatment is insufficient—natural clearance without any treatment is even less likely 2
- Chronic bacterial prostatitis affects up to 74% of cases with persistent gram-negative or gram-positive organisms when inadequately treated, with Enterococcus species being a significant contributor 1
Treatment Requirements for Enterococcus Prostatitis
- For health care-associated infections, antimicrobial therapy for enterococci should be given when recovered from patients, as recommended by the Infectious Diseases Society of America 3
- Empiric anti-enterococcal therapy should be directed against Enterococcus faecalis, with antibiotics including ampicillin, piperacillin-tazobactam, or vancomycin based on susceptibility testing, as recommended by the Infectious Diseases Society of America 3
- Treatment duration for chronic bacterial prostatitis requires 2-4 weeks minimum, with some cases requiring extended courses up to 2-3 months to achieve cure, as recommended by the American Urological Association 1
Critical Pitfall to Avoid
- Any symptomatic patient or patient with significant tissue manipulation (such as prostatectomy) requires immediate antimicrobial therapy, as recommended by the European Association of Urology 4
Resistance Considerations
- Vancomycin resistance, while still uncommon, has been reported and represents a concerning development requiring culture-directed therapy, as recommended by the Infectious Diseases Society of America 3